HealthTech

Devoted Health, a healthcare plans provider for Medicare seniors, closed $366M in Series F funding across two tranches in January 2024.

Garner Health raised $100M in Series E for healthcare provider discovery platform, reaching $2.74B valuation.

Clinical trial patient screening is the primary bottleneck in bringing oncology drugs to market, accounting for up to 25% of coordinator time at oncology sites.

Oncology trials represent 41% of all clinical trials globally with 58% growth over past decade, driven by AI-assisted drug discovery and WHO projections of 77% cancer case increase by 2050.

LLM-powered AI is now enabling previously unsolvable clinical workflows, specifically reasoning over long multimodal medical records where keyword search fails.

Battery Ventures led Triomics' latest financing round. Triomics is an AI infrastructure company solving clinical trial patient matching in oncology with 95% accuracy and customers including MSK, MD Anderson, and Yale Cancer Center.

MiRus raised $1.5B corporate round for orthopedic and spinal implants, demonstrating strong strategic investor interest in next-generation medical device technologies.

Outcome-based financing models in fertility care that shift from fee-for-service to risk-sharing arrangements represent a significant innovation in healthcare payment structures.

Fertility startup investment has remained between $100-200M annually since 2021 peak, with 2024 reaching $194.8M, indicating sustained VC interest in the sector.

VCs are recognizing fertility as an underserved healthcare market with mission-driven, commercially compelling business models that align incentives across patients, clinics, and financing.